FIELD: prophylactic medicine. SUBSTANCE: the present innovation deals with prophylactic treatment of inflammatory mucosal diseases of different etiology and represents vinylinum-based biologically active additive to regulate and normalize the activity of gastro-intestinal system. EFFECT: higher efficiency. 2 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
BISCHOFITE DOSAGE FORM FOR TREATING PYOINFLAMMATORY PROCESSES OF MUCOSAE AND SKIN | 2011 |
|
RU2469705C1 |
COMPLEX BIOLOGICALLY ACTIVE PREPARATION | 1996 |
|
RU2139060C1 |
DENTAL ELIXIR FOR MOUTH CAVITY CARE | 1993 |
|
RU2049463C1 |
AGENT FOR WOUNDS, BURNS AND INFECTIOUS INFLAMMATORY DISEASES OF SKIN, APPENDAGES AND MUCOUS MEMBRANES | 2010 |
|
RU2452475C2 |
COMPOSITE FOR ACCELERATED HEALING OF WOUNDS OF VARIOUS AETIOLOGIES, USE OF COMPOSITE AS COSMETIC AGENT AND AS A THERAPEUTIC AGENT IN VETERINARY SCIENCE, AGENT FOR SKIN REGENERATION BASED ON COMPOSITE | 2017 |
|
RU2693228C2 |
METHOD OF OBTAINING EXTRACT POSSESSING ANTI-LEPROSY ACTIVITY | 2009 |
|
RU2410111C1 |
ENCAPSULATED LYPOSOMAL ANTIVIRAL AGENT BASED ON HUMAN INTERFERON ALPHA-2b FOR VAGINAL APPLICATION | 2014 |
|
RU2552851C1 |
LIPOSOMAL AGENT FOR TREATING CHRONIC ATROPHIC GASTRITIS | 2019 |
|
RU2724021C1 |
ANTIMICROBIAL COMPOSITION FOR TREATMENT OF WOUNDS AND BURNS | 2011 |
|
RU2481834C2 |
METHOD OF VARIOUS SUPPULATIVE-INFLAMMATORY SKIN AND MUCOUS PROCESS TREATMENT | 2005 |
|
RU2326681C2 |
Authors
Dates
2003-10-20—Published
2002-09-03—Filed